Despite the lack of improvement in glucose tolerance, we did observe an improvement in fasting insulin and insulin resistance index in the mice treated with anti-CD40L antibody at the 16 week time point (Figure 8B). This evidence concerns the gene CD40LG and Insulin resistance.